GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...

DatoDurian, Malaysia's first live agriculture tokenization project, proudly announces the completion of its private sale, selling 100% of the initial round. This milestone, achieved ahead of schedule, ...

The shortage of certain types of influenza vaccines could end as early as next month with the arrival of new stock, says ...

Malaysia’s health ministry said there is no rising trend of influenza cases in Malaysia. Read more at straitstimes.com.

KUALA LUMPUR, Feb 9 — Health Minister Datuk Seri Dzulkefly Ahmad said there was no cause for worry over the shortage of ...

I also asked ChatGPT to find a substitute for its next pick, pharmaceutical giant AstraZeneca. Unsurprisingly, it picked rival GSK. GSK has been trailing AstraZeneca for years, but in my view looks ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

2025 Core Operating Profit and EPS Guidance: Expected to increase between 6% and 8%. GSK PLC (NYSE:GSK) reported an 8% increase in sales for 2024, reaching over GBP31 billion, driven by strong ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline. It came as the boss of the London-listed firm cheered an "excellent" performance ...